Subcutaneous Compared with Intravenous Epoetin in Patients Receiving Hemodialysis

Abstract

In patients receiving hemodialysis, subcutaneous administration of epoetin can maintain the hematocrit in a desired target range, with an average weekly dose of epoetin that is lower than with intravenous administration.